Novo Nordisk A/S (NVO)
112.12
+3.69 (+3.40%)
USD |
NYSE |
Jun 24, 16:00
112.10
-0.02 (-0.02%)
After-Hours: 20:00
Novo Nordisk PE Ratio: 33.38 for June 24, 2022
PE Ratio Chart
Historical PE Ratio Data
| Date | Value |
|---|---|
| June 24, 2022 | 33.38 |
| June 23, 2022 | 32.29 |
| June 22, 2022 | 31.96 |
| June 21, 2022 | 32.13 |
| June 17, 2022 | 31.44 |
| June 16, 2022 | 31.47 |
| June 15, 2022 | 31.66 |
| June 14, 2022 | 31.60 |
| June 13, 2022 | 32.03 |
| June 10, 2022 | 33.20 |
| June 09, 2022 | 33.59 |
| June 08, 2022 | 34.53 |
| June 07, 2022 | 34.50 |
| June 06, 2022 | 33.39 |
| June 03, 2022 | 33.47 |
| June 02, 2022 | 33.54 |
| June 01, 2022 | 32.85 |
| May 31, 2022 | 32.87 |
| May 27, 2022 | 32.08 |
| May 26, 2022 | 31.74 |
| May 25, 2022 | 31.34 |
| May 24, 2022 | 32.15 |
| May 23, 2022 | 32.11 |
| May 20, 2022 | 32.08 |
| May 19, 2022 | 30.98 |
| Date | Value |
|---|---|
| May 18, 2022 | 30.82 |
| May 17, 2022 | 31.66 |
| May 16, 2022 | 30.74 |
| May 13, 2022 | 31.57 |
| May 12, 2022 | 31.07 |
| May 11, 2022 | 30.91 |
| May 10, 2022 | 31.99 |
| May 09, 2022 | 31.64 |
| May 06, 2022 | 33.16 |
| May 05, 2022 | 33.58 |
| May 04, 2022 | 33.92 |
| May 03, 2022 | 33.70 |
| May 02, 2022 | 33.90 |
| April 29, 2022 | 33.94 |
| April 28, 2022 | 32.81 |
| April 27, 2022 | 33.22 |
| April 26, 2022 | 32.69 |
| April 25, 2022 | 33.86 |
| April 22, 2022 | 32.96 |
| April 21, 2022 | 32.98 |
| April 20, 2022 | 34.40 |
| April 19, 2022 | 34.07 |
| April 18, 2022 | 34.65 |
| April 14, 2022 | 35.20 |
| April 13, 2022 | 35.40 |
Price to Earnings Ratio (PE Ratio) Definition
The Price to Earnings Ratio (PE Ratio) is calculated by taking the stock price / EPS (ttm). This metric is considered a valuation metric that confirms whether the earnings of a company justifies the stock price. There isn't necesarily an optimum PE ratio, since different industries will have different ranges of PE Ratios. Because of this, PE Ratio is great to evaluate from a relative standpoint with other similar companies.
PE Ratio Range, Past 5 Years
16.46
Minimum
Oct 11 2018
36.43
Maximum
Dec 16 2021
24.27
Average
23.49
Median
Apr 08 2020
PE Ratio Benchmarks
| Eli Lilly and Co | 48.89 |
| Ascendis Pharma A/S | -- |
| Zealand Pharma A/S | -- |
| Forward Pharma A/S | -- |
| Verona Pharma PLC | -- |
PE Ratio Related Metrics
| PS Ratio | 11.07 |
| PEG Ratio | 2.056 |
| Price to Book Value | 25.43 |
| Price to Free Cash Flow | 27.71 |
| Price | 112.12 |
| Earnings Yield | 3.00% |
| Market Cap | 253.98B |
| PEGY Ratio | 1.892 |
| Operating PE Ratio | 26.26 |
| Normalized PE Ratio | 33.38 |